Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$24.99

Operating Profit Margin
since 2005

Microsoft Excel

Paying user area

Try for free

Abbott Laboratories pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Abbott Laboratories, operating profit margin, long-term trends, calculation

Microsoft Excel
Operating profit margin = 100 × Operating earnings1 ÷ Net sales1
Dec 31, 2025 = 100 × ÷
Dec 31, 2024 = 100 × ÷
Dec 31, 2023 = 100 × ÷
Dec 31, 2022 = 100 × ÷
Dec 31, 2021 = 100 × ÷
Dec 31, 2020 = 100 × ÷
Dec 31, 2019 = 100 × ÷
Dec 31, 2018 = 100 × ÷
Dec 31, 2017 = 100 × ÷
Dec 31, 2016 = 100 × ÷
Dec 31, 2015 = 100 × ÷
Dec 31, 2014 = 100 × ÷
Dec 31, 2013 = 100 × ÷
Dec 31, 2012 = 100 × ÷
Dec 31, 2011 = 100 × ÷
Dec 31, 2010 = 100 × ÷
Dec 31, 2009 = 100 × ÷
Dec 31, 2008 = 100 × ÷
Dec 31, 2007 = 100 × ÷
Dec 31, 2006 = 100 × ÷
Dec 31, 2005 = 100 × ÷

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions

The operating profit margin exhibited considerable fluctuation between 2005 and 2025. Initial values demonstrated a strong profitability level, followed by periods of decline, recovery, and ultimately, renewed strength. A detailed examination of the period reveals distinct phases in the company’s operational performance.

Initial Period (2005-2009)
The operating profit margin began at 19.53% in 2005, experienced a significant decrease to 9.09% in 2006, and then demonstrated a recovery, reaching 20.27% by 2009. This period suggests initial volatility followed by a return to, and slight exceeding of, the initial profitability level. The increase from 2008 to 2009 is particularly notable.
Period of Moderation (2010-2013)
From 2010 through 2013, the operating profit margin generally trended downwards, although with some variation. It decreased from 17.31% in 2010 to a low of 12.03% in 2013. This suggests a period where cost pressures or pricing challenges impacted operational profitability. The decline in net sales during 2013 likely contributed to this reduced margin.
Fluctuating Performance (2014-2017)
The years 2014 to 2017 were characterized by fluctuating performance. The margin increased from 12.84% in 2014 to 15.27% in 2016, before experiencing a dramatic drop to 6.30% in 2017. This substantial decline in 2017 warrants further investigation, as it represents a significant deviation from the preceding trend. The increase in net sales in 2017 did not translate to improved profitability.
Recovery and Growth (2018-2021)
A clear recovery began in 2018, with the operating profit margin steadily increasing from 11.94% to 19.56% in 2021. This period demonstrates successful implementation of cost control measures, improved pricing strategies, or favorable market conditions. The substantial growth in net sales from 2018 through 2021 appears to have positively impacted profitability.
Recent Performance (2022-2025)
From 2022 to 2025, the operating profit margin remained relatively high, fluctuating between 16.15% and 18.17%. While not exhibiting the same rate of growth as the 2018-2021 period, the margin remained consistently above 16%, indicating sustained operational efficiency and profitability. The slight increase from 2024 to 2025 suggests continued positive momentum.

Overall, the operating profit margin demonstrates a cyclical pattern with periods of volatility, decline, recovery, and sustained profitability. The most significant fluctuations occurred between 2005-2009 and 2014-2017, while the period from 2018-2025 indicates a more stable and positive trend.

Comparison to Competitors

Abbott Laboratories, operating profit margin, long-term trends, comparison to competitors

Microsoft Excel
Abbott Laboratories Intuitive Surgical Inc. Medtronic PLC UnitedHealth Group Inc.
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 31, 2014
Dec 31, 2013
Dec 31, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 31, 2008
Dec 31, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).